How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Nov 10, 2025
0
11
MeSH tree: C04.588.945.947
Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Nov 10, 2025
0
11
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.
Nov 3, 2025
0
25
FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs of clinical benefit in patients with advanced urothelial carcinoma, according ...
Oct 22, 2025
0
9
KEYMAKER-U03 is an international, multicenter, open-label, Phase I/II umbrella trial evaluating experimental combinations of pembrolizumab-based immunotherapy and targeted treatments for advanced clear cell renal cell carcinoma ...
Oct 21, 2025
0
25
A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.
Oct 20, 2025
0
16
Results from a trial led by researchers from The University of Texas MD Anderson Cancer Center showed that a targeted therapy combination improved outcomes for patients with metastatic clear-cell renal carcinoma (ccRCC)—a ...
Oct 20, 2025
0
19
Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, and smoking is the main known environmental risk factor. However, the biological mechanisms behind ...
Oct 8, 2025
0
19
The bladder is easy to overlook—until it starts causing trouble. This small, balloon-like organ in the lower urinary tract quietly stores and releases urine, helping the body eliminate waste and maintain fluid balance.
Oct 6, 2025
0
16
You can always be judged by your scars. This is the idea that sums up one of the new advances in basic and biomedical research published in the journal Science by the Spanish National Cancer Research Center (CNIO). It is ...
Oct 2, 2025
0
27
Researchers at London Health Sciences Center Research Institute (LHSCRI) have launched a Phase II clinical trial that aims to treat renal cell carcinoma (kidney cancer) by inserting microscopic beads filled with radiation ...
Oct 2, 2025
0
16